What is the Share Price of Vimta Labs Ltd?
- Answer Field
-
The share price of Vimta Labs Ltd for NSE is ₹ 998.9 and for BSE is ₹ 1001.75.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, VIMTA LABS LIMITED share price is currently at ₹ 998.9, which is down by ₹ -38.69 from its previous closing. Today, the stock has fluctuated between ₹ 991.30 and ₹ 1046.30. Over the past year, VIMTA LABS LIMITED has achieved a return of 86.44 %. In the last month alone, the return has been 3.48 %. Read More...
Particulars | MAR 2025 (Values in Cr) |
---|---|
Revenue | 94.44 |
Operating Expense | 71.06 |
Net Profit | 18.32 |
Net Profit Margin (%) | 19.39 |
Earnings Per Share (EPS) | 8.22 |
EBITDA | 34.68 |
Effective Tax Rate (%) | 26.80 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
APOLLO HOSPITALS ENTER. L | 6962.05 | 76.41 | 13.35 | 100103.60 | 5690.80 / 7545.10 |
FORTIS MALAR HOSPITALS LIMITED | 75.38 | 183.85 | 4.73 | 141.28 | 51.01 / 98.70 |
SHREE PACETRONIX LTD. | 70.00 | 14.58 | 1.87 | 25.20 | 61.11 / 268.50 |
TRANSGENE BIOTEK LTD. | 3.68 | 0.00 | 2.57 | 27.88 | 3.22 / 10.84 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
APOLLO HOSPITALS ENTER. L | 6962.05 | 83.30 | 12.22 | 100103.60 | 5690.80 / 7545.10 |
Surlux Diagnostic Ltd | 1.40 | 0.84 | 0.13 | 0.49 | 0.00 / 0.00 |
CHENNAI MEENAKSHI MULTISPECIAL | 32.25 | 0.00 | -17.27 | 24.09 | 28.34 / 59.90 |
KOVAI MEDICAL CENTER & HOSPITA | 5560.50 | 29.47 | 6.24 | 6083.19 | 3750.00 / 6400.00 |
Vimta Labs Ltd., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.
In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.
During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.
During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.
During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.
In 2023-24, Emtac Laboratories Private Limited got amalgamated with the Company effective 01.04.2024.
The share price of Vimta Labs Ltd for NSE is ₹ 998.9 and for BSE is ₹ 1001.75.
The market cap of Vimta Labs Ltd for NSE is ₹ 22,14.62 Cr. and for BSE is ₹ 22,20.93 Cr. as of now.
The 52 Week High and Low of Vimta Labs Ltd for NSE is ₹ 1178.00 and ₹ 420.00 and for BSE is ₹ 1183.00 and ₹ 420.00.
You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 86.44%.
Vimta Labs Ltd share price is for NSE ₹ 998.9 & for BSE ₹ 1001.75 as on Apr 30 2025 03:30 PM.
The market cap of Vimta Labs Ltd for NSE ₹ 22,14.62 & for BSE ₹ 22,20.93 as on Apr 30 2025 03:30 PM.
As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Vimta Labs Ltd share is 33.03.
As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Vimta Labs Ltd share is 170.38.
You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a demat account.
To buy Vimta Labs Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Vimta Labs Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found